Karla A. Henning

2.6k citations

23 papers · 1.9k indexed · 1 hit paper · h-index 12

Molecular Biology top 10%
Oncology top 5%
Immunology top 5%
Genetics top 10%
Hematology top 10%

Co-authors: Alan J. Korman M. S. Srinivasan M. J. Selby Michael Quigley John Engelhardt Tseng-hui Timothy Chen E C Friedberg Ruth Halaban
Topics: DNA Repair Mechanisms (7 papers)CRISPR and Genetic Engineering (7 papers)Chemokine receptors and signaling (3 papers)
Cited by: Immunology Oncology Molecular Biology
Journals: Cell Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United States Australia Germany

In The Last Decade

Karla A. Henning

21 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells

2013 670 citations M. J. Selby, John Engelhardt et al. Cancer Immunology Research profile →

Peers

Countries citing papers authored by Karla A. Henning

Since Specialization

Citations

This map shows the geographic impact of Karla A. Henning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karla A. Henning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karla A. Henning more than expected).

Fields of papers citing papers by Karla A. Henning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karla A. Henning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karla A. Henning. The network helps show where Karla A. Henning may publish in the future.

Co-authorship network of co-authors of Karla A. Henning

This figure shows the co-authorship network connecting the top 25 collaborators of Karla A. Henning. A scholar is included among the top collaborators of Karla A. Henning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karla A. Henning. Karla A. Henning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 2964: Targeting tumor-associated macrophages to enhance anti-tumor immunity with the Dectin-2 agonistic antibody BDC-3042 2023 ·Cancer Research ·Justin A. Kenkel,(unknown),Po Y. Ho,(unknown),(unknown),(unknown),(unknown),(unknown),Jason Ptacek,(unknown),Cecelia I. Pearson,(unknown),(unknown),Karla A. Henning,(unknown),Lu Xu,Steven J. Chapin,Michael N. Alonso,Shelley E. Ackerman	1
2	862 Dectin-2, a novel target for tumor macrophage reprogramming in cancer immunotherapy 2021 ·Regular and Young Investigator Award Abstracts ·Justin A. Kenkel,Po Y. Ho,Sameera Kongara,Karla A. Henning,(unknown),(unknown),(unknown),Marcin Kowanetz,Michael N. Alonso,Shelley E. Ackerman,Edgar G. Engleman,David Dornan	0
3	603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration 2020 ·SHILAP Revista de lepidopterología ·Shelley E. Ackerman,Felix J. Hartmann,Cecelia I. Pearson,Joseph C. González,Po Y. Ho,Samuel C. Kimmey,(unknown),Benjamin Ackerman,Arthur Lee,Richard Laura,Jason C. Paik,Karla A. Henning,David Jackson,(unknown),Bruce H. Devens,David Dornan,Sean C. Bendall,Edgar G. Engleman,Michael N. Alonso	1
4	PD-1 blockade enhances elotuzumab efficacy in mouse tumor models 2017 ·Blood Advances ·Natalie Bezman,(unknown),(unknown),Ty Brender,Mark Maurer,Karla A. Henning,Misty R. Jenkins,(unknown),Paul J. Neeson,Alan J. Korman,Michael Robbins,Robert F. Graziano	42
5	The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and –independent mechanisms 2017 ·OncoImmunology ·Tatiana Pazina,Ashley M. James,Alexander W. Macfarlane,Natalie Bezman,Karla A. Henning,Christine Bee,Robert F. Graziano,Michael Robbins,Adam D. Cohen,Kerry S. Campbell	64
6	Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cellsbreakdown → 2013 ·Cancer Immunology Research ·M. J. Selby,John Engelhardt,Michael Quigley,Karla A. Henning,Tseng-hui Timothy Chen,M. S. Srinivasan,Alan J. Korman	670
7	Role of the immunoglobulin constant region in the antitumor activity of antibodies to cytotoxic T-lymphocyte antigen-4 (CTLA-4). 2013 ·Journal of Clinical Oncology ·Alan J. Korman,John Engelhardt,Vafa Shahabi,Roumyana Yordanova,Karla A. Henning,Timothy F. Chen,Mark Selby	3
8	BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic Malignancies 2012 ·Clinical Cancer Research ·Michelle Kuhne,(unknown),(unknown),(unknown),Chin Pan,(unknown),Fei Cao,(unknown),(unknown),Karla A. Henning,Lewis Cohen,Alan J. Korman,Pina M. Cardarelli	181
9	Abstract #LB-150: A fully human anti-CXCR4 antibody induces apoptosis in vitro and shows anti tumor activity in vivo. 2009 ·Cancer Research ·Michelle Kuhne,(unknown),(unknown),(unknown),Chin Pan,(unknown),(unknown),(unknown),(unknown),Karla A. Henning,Lewis Cohen,Diann Blanset,Alan J. Korman,Pina M. Cardarelli	1
10	Enhanced protein production by engineered zinc finger proteins 2006 ·Biotechnology and Bioengineering ·Andreas Reik,Yuanyue Zhou,Trevor N. Collingwood,(unknown),Victor V. Bartsevich,(unknown),Karla A. Henning,(unknown),Lei Zhang,Xiaohong Zhong,Yann Jouvenot,Andrew C. Jamieson,Edward J. Rebar,Casey C. Case,Alan J. Korman,Xiaoyong Li,Amelia Black,David King,Philip D. Gregory	16
11	Humanizing the yeast telomerase template 1998 ·Proceedings of the National Academy of Sciences ·Karla A. Henning,N H Moskowitz,Melissa A. Ashlock,(unknown)	41
12	UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. 1996 ·Proceedings of the National Academy of Sciences ·David B. Bregman,Ruth Halaban,Alain J. van Gool,Karla A. Henning,E C Friedberg,Stephen L. Warren	262
13	The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH 1995 ·Cell ·Karla A. Henning,Lei Li,Narayan V. Iyer,Lisa D. McDaniel,Michael S. Reagan,Randy J. Legerski,Roger A. Schultz,Miria Stefanini,Alan R. Lehmann,Lynne V. Mayne,Errol C. Friedberg	388
14	Cloning theDrosophilahomolog of the xeroderma pigmentosum complementation group C gene reveals homology between the predicted human andDrosophilapolypeptides and that encoded by the yeastRAD4gene 1994 ·Nucleic Acids Research ·Karla A. Henning,Carolyn A. Peterson,Randy J. Legerski,Errol C. Friedberg	24
15	The conundrum of xeroderma pigmentosum — A rare disease with frequent complexities 1993 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·E C Friedberg,Karla A. Henning	13
16	Techniques and applications of microcell-mediated chromosome transfer to mammalian cells. 1993 ·Karla A. Henning,E C Friedberg,Kenneth W. Adolph	1
17	Microcell-Mediated Chromosome Transfer: A Strategy for Studying the Genetics and Molecular Pathology of Human Hereditary Diseases with Abnormal Responses to DNA Damage 1990 ·PubMed ·Errol C. Friedberg,Karla A. Henning,(unknown),Paul J. Saxon,Roger A. Schultz,Gurbax S. Sekhon,Eric J. Stanbridge	5
18	Gene complementing xeroderma pigmentosum group A cells maps to distal human chromosome 9q 1990 ·Somatic Cell and Molecular Genetics ·Karla A. Henning,Roger A. Schultz,Gurbax S. Sekhon,Errol C. Friedberg	10
19	DNA-Mediated Transfer of a Human DNA Repair Gene That Controls Sister Chromatid Exchange 1985 ·Molecular and Cellular Biology ·Larry H. Thompson,Kerry W. Brookman,J.L. Minkler,James C. Fuscoe,Karla A. Henning,A.V. Carrano	9
20	DNA-mediated transfer of a human DNA repair gene that controls sister chromatid exchange. 1985 ·Molecular and Cellular Biology ·Larry H. Thompson,Kerry W. Brookman,J.L. Minkler,James C. Fuscoe,Karla A. Henning,A.V. Carrano	41

About Karla A. Henning

Karla A. Henning is a scholar working on Immunology, Oncology and Molecular Biology, having authored 23 papers that have together received 1.9k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (7 papers), CRISPR and Genetic Engineering (7 papers) and Chemokine receptors and signaling (3 papers). The work is most often cited by research in Immunology (704 citations), Oncology (826 citations) and Molecular Biology (1.0k citations). Karla A. Henning has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Alan J. Korman, M. S. Srinivasan, M. J. Selby, Michael Quigley, John Engelhardt, Tseng-hui Timothy Chen, E C Friedberg, Ruth Halaban, Stephen L. Warren and David B. Bregman. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact